Ranq Pharmaceuticals And Excipients Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 29-12-2024
- Paid Up Capital ₹ 1.33 M
as on 29-12-2024
- Company Age 33 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.13 M
as on 29-12-2024
- Revenue -56.60%
(FY 2022)
- Profit 6.66%
(FY 2022)
- Ebitda 4.76%
(FY 2022)
- Net Worth 1.24%
(FY 2022)
- Total Assets -0.86%
(FY 2022)
About Ranq Pharmaceuticals And Excipients
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.33 M.
The company currently has active open charges totaling ₹8.13 M.
Sameer Ranadive and Janhavi Jangle serve as directors at the Company.
- CIN/LLPIN
U24230MH1991PTC062793
- Company No.
062793
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ranq Pharmaceuticals And Excipients Private Limited offer?
Ranq Pharmaceuticals And Excipients Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Pharmaceutical Excipients.
Who are the key members and board of directors at Ranq Pharmaceuticals And Excipients?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Janhavi Jangle  | Director | 18-Jul-2013 | Current |
| Sameer Ranadive | Director | 02-Aug-1991 | Current |
Financial Performance of Ranq Pharmaceuticals And Excipients.
Ranq Pharmaceuticals And Excipients Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.6% decrease. The company also saw a slight improvement in profitability, with a 6.66% increase in profit. The company's net worth moved up by a moderate rise of 1.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ranq Pharmaceuticals And Excipients?
In 2022, Ranq Pharmaceuticals And Excipients had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ranq Remedies Private LimitedActive 22 years 3 monthsSameer Ranadive and Janhavi Jangle are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 16 Aug 1995 | ₹1.60 M | Open |
Bank Of Baroda Creation Date: 02 Jun 1995 | ₹0.73 M | Open |
The Maharashtra State Financial Corpn. Creation Date: 02 Jan 1992 | ₹5.80 M | Open |
How Many Employees Work at Ranq Pharmaceuticals And Excipients?
Ranq Pharmaceuticals And Excipients has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ranq Pharmaceuticals And Excipients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranq Pharmaceuticals And Excipients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
